Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00140608 · ClinicalTrials.gov registry record · NA
Efficacy of Seprapack Sinus Dressing Versus No Dressing in the Prevention of Intranasal Adhesions Following Sinus Surgery
A NA study, sponsored by Genzyme, a Sanofi Company.
- Terminated
- Registry status
- NA
- Development phase
NCT00140608 is a NA study that was terminated before completion, run by Genzyme, a Sanofi Company.
The verdict
NCT00140608, a NA study, was terminated before completion, sponsored by Genzyme, a Sanofi Company.
- TERMINATED
- Registry status
- NA
- Development phase
Study Summary
The purpose of this study is to investigate if the space occupying effect of Seprapack will lead to a reduction in post operative adhesions and more healing of the sinus cavity when compared to the use of no packing material.
Interventions
- DEVICE Seprapack Sinus Dressing
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-06 |
| Est. Completion | 2005-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00140608
The ClinicalTrials.gov registry entry for NCT00140608 describes a study currently listed as terminated, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Genzyme, a Sanofi Company, which has 196 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Seprapack Sinus Dressing is the first listed.
NCT00140608 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00140608 about?
NCT00140608 is a clinical study titled "Efficacy of Seprapack Sinus Dressing Versus No Dressing in the Prevention of Intranasal Adhesions Following Sinus Surgery". The purpose of this study is to investigate if the space occupying effect of Seprapack will lead to a reduction in post operative adhesions and more healing of the sinus cavity when compared to the use of no packing material.
What is the current status of trial NCT00140608?
This trial is currently terminated. It is a NA study. The study started on 2003-06. Estimated completion is 2005-05.
What interventions are being tested in trial NCT00140608?
The interventions under investigation include: Seprapack Sinus Dressing (DEVICE).
Who is sponsoring clinical trial NCT00140608?
This trial is sponsored by Genzyme, a Sanofi Company, which has 196 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.